February 2015 Vol. 10 No. 2

FDA approves new drug for thyroid cancer

On February 13, the U.S. Food and Drug Administration (FDA) approved Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid…

Future forward: I am data

It’s always exciting to see nursing and nursing practice on the national stage at events like the ANA 2015 Quality…

Huddle up for patient safety

You have received report on your patients and are starting your shift on a busy medical-surgical unit. To help control…

New sleep recommendations

A panel convened by the National Sleep Foundation has issued recommendations for sleep based on age. The recommendation for young…

Quiz time

Which statement about purulent secretions is correct? a. They can be identified by color. b. They are determined by Gram…

Resting not regretting

“We are such stuff as dreams are made on, and our little life is rounded with a sleep.” — William…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.